Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
seemingly-harmless's Profile
Displaying 51-100 of 299 result(s).
CYDY CytoDyn Inc
10/03/2024 10:48:20 AM
new york times article on MASH toda (1)
CYDY CytoDyn Inc
09/25/2024 11:07:40 AM
"X" doesnt let you copy and paste? (2)
CYDY CytoDyn Inc
09/19/2024 9:44:21 PM
i would think if they (who?) found (1)
CYDY CytoDyn Inc
09/19/2024 11:36:18 AM
so when leronlimab is shown to be e (6)
CYDY CytoDyn Inc
09/18/2024 12:45:51 PM
Merck said the 5 year OS rate was (6)
CYDY CytoDyn Inc
09/10/2024 11:41:20 AM
same old story...otherwise mindbogg (3)
CYDY CytoDyn Inc
09/02/2024 7:47:20 PM
docs pushing statins on me too...ne (5)
CYDY CytoDyn Inc
08/12/2024 7:53:02 PM
a delicate situation that shorts, b (4)
CYDY CytoDyn Inc
07/18/2024 3:45:31 PM
university of cambridge and Tregs - (1)
CYDY CytoDyn Inc
07/18/2024 12:32:45 PM
...and baby CAN dance (3)
CYDY CytoDyn Inc
07/10/2024 9:48:58 PM
quercetin...i thought that is good (1)
CYDY CytoDyn Inc
07/10/2024 1:16:09 PM
red gives me migraines also...maybe (1)
CYDY CytoDyn Inc
07/09/2024 10:13:12 AM
so crime pays...very handsomely (1)
CYDY CytoDyn Inc
06/28/2024 7:41:03 PM
yes a separate arm for LL only is c (1)
CYDY CytoDyn Inc
06/22/2024 10:03:58 PM
so if leronlimab has the same trial (4)
CYDY CytoDyn Inc
06/18/2024 1:13:38 PM
so at what brain wave stage (asleep (6)
CYDY CytoDyn Inc
06/11/2024 4:34:56 PM
similar efficacy can result in appr (6)
CYDY CytoDyn Inc
06/05/2024 5:22:07 PM
i believe this is in reference to B (12)
CYDY CytoDyn Inc
06/03/2024 4:51:17 PM
summits' ivonescimab approved for u (1)
CYDY CytoDyn Inc
05/31/2024 11:58:14 AM
this is ignored because if LL is sa (2)
CYDY CytoDyn Inc
05/07/2024 5:40:51 PM
madrigal gets to use "non invasive (5)
CYDY CytoDyn Inc
04/21/2024 9:58:49 PM
and when will this ever be illegal (5)
CYDY CytoDyn Inc
04/17/2024 2:40:22 PM
did not know cabenuva injections ar (1)
CYDY CytoDyn Inc
04/11/2024 4:40:49 PM
the darkest part of this revelation (10)
CYDY CytoDyn Inc
04/10/2024 6:02:08 PM
M*F* concrete smoking gun. doesnt m (3)
CYDY CytoDyn Inc
04/04/2024 10:56:15 AM
drug pulled from market - that shou (5)
CYDY CytoDyn Inc
03/27/2024 7:06:16 PM
i just dont get it. how does insura (6)
CYDY CytoDyn Inc
03/12/2024 11:01:43 AM
not to beat a dead horse, info for (9)
CYDY CytoDyn Inc
03/11/2024 11:48:07 PM
recaps necessary for newbies - FDA (10)
CYDY CytoDyn Inc
03/09/2024 6:30:38 PM
because they (FDA) are untouchable, (3)
CYDY CytoDyn Inc
03/08/2024 9:55:22 AM
FDA: alzheimers drug pause on donan (4)
CYDY CytoDyn Inc
03/06/2024 12:25:24 PM
yes but the FDA has guided / toyed (2)
CYDY CytoDyn Inc
03/06/2024 9:58:19 AM
im trying to have faith, but 90 pow (1)
CYDY CytoDyn Inc
02/14/2024 2:02:25 PM
how much cash can amarex "afford" o
CYDY CytoDyn Inc
02/12/2024 12:30:17 PM
gilead liver disease purchase https (2)
CYDY CytoDyn Inc
02/08/2024 5:59:27 PM
"you're new here aren't you" is my (3)
CYDY CytoDyn Inc
02/08/2024 5:11:20 PM
regarding patents - have read a few
CYDY CytoDyn Inc
01/10/2024 12:02:17 PM
friend got vax booster last week an (6)
CYDY CytoDyn Inc
01/03/2024 9:36:42 PM
...and do other HIV on market drugs
CYDY CytoDyn Inc
12/20/2023 4:16:14 PM
off label use is the biggest threat (7)
CYDY CytoDyn Inc
12/16/2023 10:05:25 PM
i recall NDAs being in place years (2)
CYDY CytoDyn Inc
12/15/2023 10:36:20 AM
the first thing dr j said was that (1)
CYDY CytoDyn Inc
12/14/2023 10:53:55 PM
clarity please on "second hold" - d (6)
CYDY CytoDyn Inc
12/12/2023 9:24:14 PM
my time comin, any day now (2)
CYDY CytoDyn Inc
11/20/2023 5:29:04 PM
we have learned that the FDAs and B
CYDY CytoDyn Inc
11/18/2023 2:05:35 PM
entirely new trial request indicate (5)
CYDY CytoDyn Inc
11/18/2023 9:21:16 AM
so merck has no option but to make (3)
CYDY CytoDyn Inc
11/17/2023 7:16:07 PM
then why even bother to do the comb (4)
CYDY CytoDyn Inc
11/16/2023 10:22:39 PM
release of keytruda/LL data - when (2)
CYDY CytoDyn Inc
11/13/2023 7:13:36 PM
i am missing this also...if this dr (5)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • Crane NXT's Strategic Move: Acquiring Antares Vision for Growth
  • AB Akola Group Aims for Growth in Feed Production Capacity
  • Crane NXT's Strategic Move to Enhance Inspection Technologies
  • Uber's Legal Battle Over Disabled Rider Discrimination Claims
  • Transforming Live Streaming: Innovations from Akamai and Harmonic
  • Kroger's Strategic Pricing Approach to Enhance Customer Value
  • Ascendancy of Silver-Backed Crypto and Its Impact on Bitcoin
  • Rising Demand for Portable Gaming Consoles: Key Insights Ahead
  • Crédit Agricole S.A. Exciting Announcement About Note Redemption
  • Bekaert's Share Buyback Update and Liquidity Activity Explained
  • Irish Continental Group Makes Strategic Share Purchases
  • Foresight Group Engages in Strategic Share Buyback Initiative
  • New Developments for OSE Immunotherapeutics' Upcoming Meeting
  • Exploring NB Private Equity Partners' Recent Share Buyback Activity
  • OSB Group PLC Enhances Shareholder Value Through Buybacks
  • Join Norsk Hydro for a Special Investor Day in London
  • Rackspace Technology Secures AWS Automotive Competency Status
  • Significant Developments in OSE Immunotherapeutics Shareholder Agreement
  • Join Us for Norsk Hydro's Exciting Investor Day in London
  • Microsoft's Leadership Faces Protests Amid Controversial Allegations
  • OneOdio and OpenRock Shine Bright at IFA 2025 Showcase
  • Trinasolar Achieves Tier 1 Status for Renewable Energy Solutions
  • United Imaging Intelligence Achieves Major Milestone in AI
  • Virtualware Strengthens Vocational Training with Major VIROO Deal
  • BigBear.ai Stock Sees Rise Following Airport Technology Launch
  • IASO Bio's Groundbreaking CAR-T Therapy Showcased for MS
  • Euronext's Journey Toward Joining the CAC 40 Index
  • Sampo plc Announces Share Buybacks Strategy and Details
  • Waymo's Rise: Tesla Bull Applauds While Competing in the Market
  • HCW Biologics Skyrockets Following Promising Cancer Treatment
  • Pluxee's Strategic Move: Acquiring ProEves for Growth
  • Traveland RV Expands Its Reach with Minard's Leisure World Acquisition
  • Pluxee's Strategic Acquisition of ProEves: Transforming Childcare Benefits
  • Bigbank AS Successfully Completes AT1 Bond Offering Event
  • TikTok Shop Showcases Innovative Fall Trends for 2025
  • Ross Gerber Questions Tesla's Path to Full Autonomy and Growth
  • Leads Biolabs Continues Innovative Trials for Advanced Melanoma
  • URBAN REVIVO Unveils Spectacular Flagship Store in London
  • Kyndryl and VML Partnership Revolutionizes Customer Engagement
  • VinFast Emphasizes Electric Future at Electrify Expo Chicago
  • Mexico's Tariff Plans: A Serious Warning from China
  • Dogecoin Soars Amid ETF Hype and Market Trends
  • Opendoor's New CEO Kaz Nejatian Promises Value Growth
  • Elizabeth Warren Critiques Paramount Skydance's Bid for WBD
  • Strathcona Resources Enhances Proposal for MEG Energy Shares
  • Kyndryl and VML Join Forces to Revolutionize Customer Interactions
  • TCL's FreshIN 3.0 Air Conditioner Wins Award for Innovation
  • Experience Thrilling Rally Racing at Overmountain Rally 2025
  • Gemini Aims for Big Market Impact with $425 Million IPO
  • Fiji Airways Achieves Prestigious Recognition in Aviation
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site